ArticleIrish journal of medical science2025
PHLPP and LAMP2 predict favorable treatment response and survival in multiple myeloma patients who receive induction treatment with bortezomib.
Qingkun Han et al.PubMed ↗Publisher ↗
No numbers read from the abstract.